Viridian Therapeutics Inc Share Price

NASDAQ: VRDN

Small Cap

$18.66

+0.65

(+3.61%)

as on September 17, 2025 at 1:29 am IST

$₹

Viridian Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$17.96
Day's Price Range
$18.86
$18.66
3.75%
Downside
1.07%
Upside
52 Week's Low
52 Week's High
$9.9
52-Week Price Range
$27.2
$18.66
46.95%
Downside
45.77%
Upside

Viridian Therapeutics Inc share price movements today

Previous Close: $18.01
Open: $18.28
Volume: 560.0K
Day's Low - High: $17.96 - $18.86
52 Week Low - High: $9.9 - $27.2

Viridian Therapeutics Inc Historical Returns

1 Month Return: -2.86 %
3 Month Return: + 12.99 %
1 Year Return: -16.47 %
3 Year Return: -18.14 %
5 Year Return: 0 %

Viridian Therapeutics Inc Stock Fundamentals & Key Indicators

Check Viridian Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-4.0791

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.2

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-371.1M

Revenue (TTM)

305.0K

Profit Margin

0.00%

Return On Equity TTM

28222500.00%

Viridian Therapeutics Inc Stock Valuation

Track how Viridian Therapeutics Inc P/E has moved over time to understand its valuation trends.

Viridian Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 16, 2025

Industry (0.00x)

September 16, 2025

Today (-4.20x)

September 16, 2025

Highest (0.00x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.20x

Viridian Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Viridian Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Viridian Therapeutics Inc	BUY	$1.5B	NA	-4.2	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Viridian Therapeutics Inc Stock including INR - Dollar returns

The Viridian Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Viridian Therapeutics Inc investment value today

Current value as on today

₹91,417

Returns

₹8,583

(-8.58%)

Returns from Viridian Therapeutics Inc Stock

₹13,451 (-13.45%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Viridian Therapeutics Inc Stock

Based on 21 analysts

BUY

95.24%

Buy

4.76%

Hold

0.00%

Sell

Based on 21 analysts, 95.24% of analysts recommend a 'BUY' rating for Viridian Therapeutics Inc. Average target price of $38.4

Viridian Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Viridian Therapeutics Inc.

What analysts predicted

51.41%UPSIDE

Target Price

$38.4

Current Price

$18.66

Analyzed by

21 Analysts

Target

$38.40

Viridian Therapeutics Inc target price $38.4, a slight upside of 51.41% compared to current price of $18.66. According to 21 analysts rating.

Viridian Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Viridian Therapeutics Inc Stock has decreased by -91% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-91% versus previous 30 day period

Viridian Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	-5	0	0	0	0
Operating Income	-72	-59	-51	-71	-55	-72	-83	-87	-93	-106
EBITDA	-67	-54	-46	-65	-47	-63	-75	-78	-86	-100
Interest Expense	0	0	0	0	0	0	1	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-68	-55	-47	-66	-48	-64	-76	-79	-86	-100
Income Tax Expense	0	4	0	5	0	72	-	-	-	-
Net Income	-68	-55	-47	-66	-48	-64	-76	-79	-86	-100
Net Profit Margin	-69434.69%	-76476.39%	-66194.44%	-92861.11%	-67419.44%	-90268.06%	-89173.26%	-110729.17%	-120711.11%	-134313.33%

Viridian Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	2	3	4	8	4	1	2	1	0	0
Gross Profit	0	0	-15	-22	-28	-27	2	1	-1	0
Operating Income	-11	-12	-26	-33	-41	-110	-79	-134	-254	-299
EBITDA	-11	-12	-25	-31	-40	-109	-78	-128	-234	-265
Interest Expense	0	0	0	0	0	0	0	0	1	3
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-11	-12	-26	-32	-41	-110	-79	-129	-237	-269
Income Tax Expense	-	0	0	1	0	0	0	-4	18	-269
Net Income	-11	-12	-26	-32	-42	-110	-79	-125	-237	-269
Net Profit Margin	-446.34%	-379.80%	-662.30%	-389.97%	-950.91%	-10569.90%	-2680.26%	-7079.23%	-75711.46%	-89387.09%

Viridian Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-55	-47	-66	-48	-64	-76	-79	-86	-100
Operating Cash Flow	-45	-38	-38	-45	-46	-67	-73	-92	-75
Investing Cash Flow	40	48	-169	-143	61	-84	-62	100	75
Financing Cash Flow	3	15	198	177	0	245	35	9	0
Change in Cash	-1	24	-8	-11	16	92	-100	16	1

Viridian Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-26	-32	-41	-110	-79	-129	-237	-269
Operating Cash Flow	-7	-28	-26	-36	-29	-54	-93	-184	-232
Investing Cash Flow	0	1	-29	28	-50	-74	-115	-94	-228
Financing Cash Flow	0	52	41	0	101	125	322	225	457
Change in Cash	-7	25	-14	-7	21	-3	113	-52	-3

Global Institutional Holdings in Viridian Therapeutics Inc

Funds	Holdings
FMR Inc	14.97%
BlackRock Inc	6.99%
Deep Track Capital, LP	6.59%
Kynam Capital Management, LP	5.76%
Vanguard Group Inc	5.59%

See all

Insights on Viridian Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 72.0K → 75.0K (in $), with an average increase of 4.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 83.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 129.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 6 quarters, -48.54M → -100.73M (in $), with an average decrease of 16.2% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, VRDN stock has moved down by -9.1%

About Viridian Therapeutics Inc

miragen therapeutics, inc., (nasdaq: mgen), is a biopharmaceutical company discovering and developing innovative microrna (mirna)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. the company leverages in-house expertise in mirna biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners. at miragen, we recognize the importance of creating strategic relationships within the biotech and pharmaceutical industries and with academic institutions globally. this collaborative approach is making important contributions in our efforts to create mirna-targeting therapies. miragen’s areas of focus include hematological malignancies, pathological fibrosis, neuro-degeneration, and cardiovascular disease. in 2011, the company formed a strategic partnership with servier, a privately-run, french research

Organisation	Viridian Therapeutics Inc
Headquarters	221 Crescent Street, Waltham, MA, United States, 02453
Industry	Healthcare
CEO	Mr. Stephen F. Mahoney J.D., MBA
E-voting on shares	Click here to vote

Key Management of Viridian Therapeutics Inc

Name	Title
Dr. Marvin H. Caruthers Ph.D.	Co-Founder & Scientific Advisory Board Member
Mr. Stephen F. Mahoney J.D., MBA	CEO, President & Director
Mr. Thomas W. Beetham J.D., MBA	Chief Operating Officer
Dr. Eric N. Olson Ph.D.	Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael R. Bristow M.D., Ph.D.	Co-Founder & Member of the Scientific Advisory Board
Mr. Vahe Bedian Ph.D.	Co-Founder & Scientific Advisor
Ms. Melissa Manno	Chief Human Resources Officer
Mr. Anthony Casciano	Chief Commercial Officer
Mr. Seth Harmon	Chief Financial Officer
Ms. Jennifer Tousignant J.D.	Chief Legal Officer

FAQs

What is Viridian Therapeutics Inc share price today?

Viridian Therapeutics Inc share price today is $18.66 as on September 17, 2025 at 1:29 am IST at the close of the market. Viridian Therapeutics Inc share today touched a day high of $18.86 and a low of $17.96.

What is the 52 week high and 52 week low for Viridian Therapeutics Inc share?

Viridian Therapeutics Inc share touched a 52 week high of $27.2 on November 12, 2024 and a 52 week low of $9.9 on April 9, 2025. Viridian Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $18.66,which is 31.40% down from its 52 week high and 88.48% up from its 52 week low.

What is Viridian Therapeutics Inc's market capitalisation today?

Viridian Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Viridian Therapeutics Inc Stock (VRDN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Viridian Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viridian Therapeutics Inc Shares that will get you 0.0804 shares as per Viridian Therapeutics Inc share price of $18.66 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Viridian Therapeutics Inc Stock (VRDN) from India?

Indian investors can start investing in Viridian Therapeutics Inc (VRDN) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Viridian Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 10:43 am IST). Based on Viridian Therapeutics Inc share’s latest price of $18.66 as on September 17, 2025 at 1:29 am IST, you will get 0.5359 shares of Viridian Therapeutics Inc. Learn more about fractional shares .